Variant report
Variant | esv3451759 |
---|---|
Chromosome Location | chr1:9566735-9590683 |
allele | n/a |
Outlinks | Ensembl   UCSC |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:9555800-9599400 | Weak transcription | Right Atrium | heart |
2 | chr1:9566000-9570200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr1:9566400-9566800 | Enhancers | Liver | Liver |
4 | chr1:9566600-9566800 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
5 | chr1:9566800-9571200 | Weak transcription | Liver | Liver |
6 | chr1:9570200-9570400 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
7 | chr1:9570200-9570600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
8 | chr1:9570200-9570600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
9 | chr1:9570200-9570600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
10 | chr1:9570600-9580400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
11 | chr1:9571200-9571600 | Enhancers | Liver | Liver |
12 | chr1:9571200-9571600 | Active TSS | HepG2 | liver |
13 | chr1:9571400-9571600 | Bivalent Enhancer | Placenta | Placenta |
14 | chr1:9571600-9571800 | Enhancers | Placenta | Placenta |
15 | chr1:9571600-9571800 | Flanking Active TSS | HepG2 | liver |
16 | chr1:9571600-9572800 | Weak transcription | Liver | Liver |
17 | chr1:9571800-9572600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
18 | chr1:9571800-9575600 | Weak transcription | HepG2 | liver |
19 | chr1:9573200-9573400 | Enhancers | Liver | Liver |
20 | chr1:9575600-9576000 | Enhancers | HepG2 | liver |
21 | chr1:9576000-9576200 | Weak transcription | HepG2 | liver |
22 | chr1:9576200-9577600 | Enhancers | HepG2 | liver |
23 | chr1:9576400-9576800 | Enhancers | Dnd41 | blood |
24 | chr1:9578400-9581000 | Enhancers | Skeletal Muscle Male | skeletal muscle |
25 | chr1:9578600-9579000 | Active TSS | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
26 | chr1:9578800-9580800 | Enhancers | Skeletal Muscle Female | skeletal muscle |
27 | chr1:9579000-9590400 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
28 | chr1:9579400-9579600 | Bivalent Enhancer | Primary T cells fromperipheralblood | blood |
29 | chr1:9579400-9579600 | Bivalent/Poised TSS | HSMM | muscle |
30 | chr1:9579800-9581000 | Enhancers | H1 Cell Line | embryonic stem cell |
31 | chr1:9580000-9580800 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
32 | chr1:9580200-9580800 | Active TSS | Spleen | Spleen |
33 | chr1:9580400-9580600 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
34 | chr1:9580400-9581000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
35 | chr1:9580400-9581000 | Enhancers | HepG2 | liver |
36 | chr1:9580600-9580800 | Flanking Bivalent TSS/Enh | H1 Derived Mesenchymal Stem Cells | ES cell derived |
37 | chr1:9580600-9581000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
38 | chr1:9580600-9581000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
39 | chr1:9580600-9581000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
40 | chr1:9581000-9581400 | Weak transcription | HepG2 | liver |
41 | chr1:9581000-9587000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
42 | chr1:9581400-9581600 | Enhancers | HepG2 | liver |
43 | chr1:9581600-9585400 | Weak transcription | HepG2 | liver |
44 | chr1:9582400-9582600 | Active TSS | K562 | blood |
45 | chr1:9582600-9582800 | Flanking Active TSS | K562 | blood |
46 | chr1:9582800-9583000 | Enhancers | K562 | blood |
47 | chr1:9583000-9585200 | Weak transcription | K562 | blood |
48 | chr1:9585000-9586800 | Enhancers | Monocytes-CD14+_RO01746 | blood |
49 | chr1:9585000-9587200 | Enhancers | Primary monocytes fromperipheralblood | blood |
50 | chr1:9585200-9585400 | Enhancers | K562 | blood |